CellWell record HH-234323
Intermittent fasting to treat diabetes: time to update clinical practice guidelines
Varady KA; Chow LS; Peterson CM
The lancet. Diabetes & endocrinology ยท 2026
In plain language
This review of trials in type 2 diabetes reports intermittent fasting lowered HbA1c by about 0.3-1.2% and matched calorie restriction, while data in gestational diabetes remain insufficient to recommend it.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-234323
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.